Skip to content

Pharminent

cropped-ChatGPT-Image-May-26-2026-09_44_59-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Pipeline
  • Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases
  • Pipeline

Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases

BioSpace

George Church's Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.

Gene Therapy Platform

Read full story

pharminent April 27, 2026 (Last updated: April 27, 2026)

BioSpace

George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.

Gene Therapy Platform

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: J&J puts blockbuster blood thinner Xarelto on TrumpRx
Next: GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

Related Stories

  • Pipeline

In Alzheimer’s, Bristol Myers sees big promise beyond amyloid

pharminent May 21, 2026
  • Pipeline

Remepy’s hybrid Parkinson’s therapy poised for phase 3

pharminent May 20, 2026
  • Pipeline

Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

pharminent May 20, 2026

You May Have Missed

wp_feature_2026-05-27
  • News

pharminent May 27, 2026
  • M&A / Deals

Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss

pharminent May 27, 2026
  • Commercial

Kardigan targets IPO to support cardiology pipeline progression

pharminent May 27, 2026
  • Regulatory

FDA delays verdict on AZ breast cancer drug

pharminent May 27, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.